First Page | Document Content | |
---|---|---|
Date: 2009-03-31 14:44:40MRI contrast agent Nephrogenic systemic fibrosis Gadolinium Gadodiamide Gadopentetic acid Magnetic resonance imaging Gadoversetamide Chemistry Matter Medicine | May[removed]OptiMARK~ (gadoversetamide injection) For Intravenous Injection Only Mallinckrodt Inc.Add to Reading ListSource URL: www.accessdata.fda.govDownload Document from Source WebsiteFile Size: 1,65 MBShare Document on Facebook |
OPTIMARK (gadoversetamide) injection LabelDocID: KSKv - View Document | |
AVAILABLE FOR PUBLIC DISCLOSURE WITHOUT REDACTION Page: 2 ofDocID: D2qm - View Document | |
Microsoft Word - GBCA Advisory Committee Meeting Briefing Document - Optimark - Errata.docDocID: Cets - View Document | |
OptiMARKā¢ 0.5 mmol/mL (Gadoversetamide Injection) PRESCRIBING INFORMATION Rx only Mallinckrodt Inc. May 2013DocID: oanB - View Document | |
May[removed]OptiMARK~ (gadoversetamide injection) For Intravenous Injection Only Mallinckrodt Inc.DocID: j2xA - View Document |